Aliases: Inapsine
Indications: Agitation, Atraumatic Headache, Nausea/Vomiting, Vertigo, Acute exacerbation of chronic abdominal pain
Contraindications: Hypersensitivity to drug, patients with signs of severe prolonged QTc
Concentrations:
Injection: 2.5 mg/mL
Dosing
Adult:
| Indication | Dose | Route | Note |
| Agitation/Psychosis | 10mg | IM | Give once. Trend RASS score every 5 minutes. Treat accordingly |
| Agitation/Psychosis | 5mg | IV | Give once. Trend RASS score every 5 minutes. Treat accordingly |
| -Atraumatic Headache -Nausea/Vomiting -Dizziness/Vertigo -Acute exacerbation of chronic abdominal pain | 2.5mg | IV/IM | May repeat once after 10 minutes. |
Pediatric:
| Indication | Dose | Route | Note |
| Agitation/Psychosis | 0.1mg/kg Max: 10mg | IM | Give once. Trend RASS score every 5 minutes. Treat accordingly |
| Agitation/Psychosis | 0.1mg/kg Max: 5mg | IV | Give once. Trend RASS score every 5 minutes. Treat accordingly |
| -Atraumatic Headache -Nausea/Vomiting -Dizziness/Vertigo -Acute exacerbation of chronic abdominal pain | 0.1mg/kg Max: 2.5mg | IV/IM | Give once. |
Precautions: ECG monitor must be applied as soon as possible when medication is given.
Adverse/Side Effects: Neuroleptic malignant syndrome, sinus tachycardia, hypotension, akathisia, dystonic reaction, restlessness, drowsiness, anxiety
Class: Butyrophenone neuroleptic.
Mechanism of Action: Like haloperidol, droperidol antagonizes multiple receptor sites in the CNS including serotonin, GABA, norepinephrine, and especially, dopamine. There is evidence that butyrophenones antagonize dopamine-mediated neurotransmission at the synapse as well as block postsynaptic dopamine receptor sites. The antiemetic activity of droperidol is most likely due to blockade of dopamine receptors in the chemoreceptor trigger zone of the brain. It is associated with prolongation of the QTc interval and serious arrhythmias including torsade de pointes. Droperidol delays the recharging of potassium channels, thereby blocking the rapid component of the delayed rectifier potassium current, within minutes of a dose at the upper limit of the dosage range.
| Onset of Action | Peak Effect | Duration of Action |
| 3-10 minutes | 30 minutes | 2-4 hours |